Non-kinase targeting of oncogenic c-jun n- terminal kinase (jnk) signaling: the future of clinically viable cancer treatments

HIGHLIGHTS

  • who: Biochemical Society Transactions ( et al. from the Garvan Institute, UNSW, Sydney, Australia have published the research work: Non-kinase targeting of oncogenic c-Jun N- terminal kinase (JNK) signaling: the future of clinically viable cancer treatments, in the Journal: (JOURNAL) of 30/08/2022
  • what: The authors aim to summarize their distinct mechanisms of action review some of the insights they have provided regarding JNK-targeting in cancer and outline the limitations as well as challenges of all strategies that target JNKs directly.
  • future: Whilst further work is required to fully resolve . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?